Publications by authors named "Antonio Calles"

40Publications

Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice.

Expert Opin Drug Saf 2020 Aug 22;19(8):1041-1048. Epub 2020 Jun 22.

Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón , Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2020.1781089DOI Listing
August 2020

Nephrotic syndrome in a 60-year-old man.

J Clin Pathol 2020 Oct 26;73(10):e3. Epub 2020 May 26.

Medical Oncology, Hospital General Universitario Gregorio Maranon, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2019-206298DOI Listing
October 2020

Checkpoint Blockade in Lung Cancer With Driver Mutation: Choose the Road Wisely.

Am Soc Clin Oncol Educ Book 2020 May;40:372-384

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_280795DOI Listing
May 2020

A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.

Eur J Cancer 2018 11 1;104:1-8. Epub 2018 Oct 1.

Medical Oncology Division, START Madrid Centro Integral Oncológico Clara Campal, Calle de Oña, 10, 28050, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.07.011DOI Listing
November 2018

For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity.

Clin Cancer Res 2019 02 27;25(4):1127-1129. Epub 2018 Sep 27.

Division of Immunology and Immunotherapy, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-2690DOI Listing
February 2019

Atezolizumab Treatment of Nonsquamous NSCLC.

N Engl J Med 2018 09;379(12):1187

Hôpitaux Universitaires de Genève, Geneva, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1809195DOI Listing
September 2018

Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer.

J Thorac Oncol 2015 Dec;10(12):1726-35

*Department of Medical Oncology, †Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; ‡Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts; §Harvard Medical School, Boston, Massachusetts; ‖Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts. ¶Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and #Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000687DOI Listing
December 2015

Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2.

Cancer Res 2015 Aug 5;75(15):3139-46. Epub 2015 Jun 5.

Lowe Center for Thoracic Oncology, Boston, Massachusetts. Department of Medical Oncology, Boston, Massachusetts. Department of Medicine, Boston, Massachusetts. Belfer Institute for Applied Cancer Science, Dana Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-3771DOI Listing
August 2015

Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma.

Clin Cancer Res 2015 Jun 3;21(12):2851-60. Epub 2015 Mar 3.

Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3112DOI Listing
June 2015

Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines.

Mol Oncol 2015 Jan 29;9(1):260-9. Epub 2014 Aug 29.

Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.08.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528687PMC
January 2015

Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study.

Target Oncol 2015 Mar 15;10(1):111-23. Epub 2014 Jun 15.

Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11523-014-0320-2
Publisher Site
http://dx.doi.org/10.1007/s11523-014-0320-2DOI Listing
March 2015

Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment.

Clin Cancer Res 2014 May 14;20(9):2476-84. Epub 2014 Mar 14.

Authors' Affiliations: Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Champions Oncology, Baltimore, Maryland; Personal Genome Diagnostics, Inc., Baltimore, Maryland; Laboratorio Dianas Terapéuticas, Hospital Universitario Madrid-Sanchinarro, Madrid, Spain; Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid-Sanchinarro, Madrid, Spain; Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322867PMC
http://dx.doi.org/10.1158/1078-0432.CCR-13-3047DOI Listing
May 2014

Primary human non-small cell lung and pancreatic tumorgraft models--utility and applications in drug discovery and tumor biology.

Curr Protoc Pharmacol 2013 Jun;Chapter 14:Unit 14.26

Clinical Research Programme, Spanish National Cancer Research Centre-CNIO, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/0471141755.ph1426s61DOI Listing
June 2013

Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.

BMC Cancer 2012 Jun 19;12:260. Epub 2012 Jun 19.

Molecular Oncology Laboratory, Medical Oncology Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (IdISSC), C/ Martin Lagos s/n, Madrid, 28040, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571914PMC
June 2012

Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer.

J Thorac Oncol 2009 Jul;4(7):891-910

Medical Oncology Department, Hospital Universitario Clínico San Carlos, Center affiliate to the Red Temática de Investigación Cooperativa (RD06/0020/0021, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153243
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e3181a4b8fbDOI Listing
July 2009